Luyi Shi Selected Research

Neoplasms (Cancer)

4/2024	A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia.
9/2023	Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luyi Shi Research Topics

Disease

2	Neoplasms (Cancer) 04/2024 - 09/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024
1	Multiple Myeloma 01/2023
1	Carcinogenesis 01/2023
1	Inflammation (Inflammations) 01/2021
1	Sepsis (Septicemia) 01/2021

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 04/2024
1	6-methyladenineIBA 01/2023

Therapy/Procedure

1	Therapeutics 04/2024
1	Drug Therapy (Chemotherapy) 09/2023
1	Splenectomy 01/2021